Literature DB >> 20452790

Central core myopathy with RYR1 mutation masks 5q spinal muscular atrophy.

R Pandey1, S Chandratre, A Roberts, J S M Dwyer, C Sewry, R Quinlivan.   

Abstract

We report the case of a male who presented in infancy with motor delay and muscle weakness. Typical muscle biopsy features and heterozygous RYR1 mutation confirmed a diagnosis of central core disease. Family studies showed this to be a de-novo mutation. Some years later, his two older teenage brothers presented with proximal muscle weakness. Neurophysiology, muscle biopsy and DNA studies confirmed spinal muscular atrophy. Subsequent genetic studies in the index case also confirmed homozygous deletions of exon 7 and 8 in the SMN gene. Review of the original muscle biopsy showed classical features of central core disease with no evidence to suggest denervation, such that the diagnosis of spinal muscular atrophy could not have been suspected in the absence of the family history.
© 2010 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452790     DOI: 10.1016/j.ejpn.2010.04.003

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  2 in total

1.  Neurofibromatosis type 1 (NF1) with an unusually severe phenotype due to digeny for NF1 and ryanodine receptor 1 associated myopathy.

Authors:  Florence Martin; Veronika Kana; Andrea Capone Mori; Dirk Fischer; Nicolas Parkin; Eugen Boltshauser; Elisabeth Jane Rushing; Andrea Klein
Journal:  Eur J Pediatr       Date:  2014-04-08       Impact factor: 3.183

2.  Silent polymorphisms in the RYR1 gene do not modify the phenotype of the p.4898 I>T pathogenic mutation in central core disease: a case report.

Authors:  Thais Cuperman; Stephanie A Fernandes; Naila C V Lourenço; Lydia U Yamamoto; Helga C A Silva; Rita C M Pavanello; Guilherme L Yamamoto; Mayana Zatz; Acary S B Oliveira; Mariz Vainzof
Journal:  BMC Res Notes       Date:  2014-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.